An adapted F-test for homogeneity of variability in follow-on biological products

Statistics in Medicine

Volumn 32, Issue 3, 2013, Pages 415-423

  Yang, Jun ^a   Zhang, Nan ^a   Chow, Shein Chung ^b   Chi, Eric ^a  

^a AMGEN INC   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adapted F test; Biosimilarity; Biosimilars; Follow on biologics; Heterogeneity of variance; Probability based method

Indexed keywords

BIOLOGICAL PRODUCT; BIOSIMILAR AGENT;

ADAPTED F TEST; ARTICLE; DRUG MANUFACTURE; DRUG QUALITY; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; PROBABILITY; STATISTICAL ANALYSIS; VARIANCE;

ALGORITHMS; BIOSIMILAR PHARMACEUTICALS; DRUG EVALUATION; MONTE CARLO METHOD; PROBABILITY; SAMPLE SIZE;

EID: 84872402838     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5568     Document Type: Article

References (11)

1. Webber KO. Biosimilars: are we there yet? Presented at Biosimilars 2007, George Washington University, Washington, DC.
2. Woodcock J, Griffin J, Behrman R, Cherney B, Crescenzi T, Fraser B, Hixon D, Joneckis C, Kozlowski S, Rosenberg A, Schranger L, Shacter E, Temple R, Webber K, Winkle H. The FDA's assessment of follow-on protein products: A historical perspective. Nature Reviews Drug Discovery 2007; 6:437-442.
3. Fox A. Biosimilar medicines-new challenges for a new class of medicine. Journal of Biopharmaceutical Statistics 2010; 20:3-9.
4. Roger SD. Biosimilars: How similar or dissimilar are they? Nephrology 2006; 11(4):341-346.
5. Roger SD, Mikhail A. Biosimilars: opportunity or cause for concern. Journal of Pharmacy & Pharmaceutical Sciences 2007; 10:405-410.
6. Chow SC, Liu JP. Statistical assessment of biosimilar products. Journal of Biopharmaceutical Statistics 2010; 20:10-30.
7. FDA. Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations, The United States Food and Drug Administration: Rockville, MD, 2003.
8. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies, 3rd edn. Chapman and Hall/CRC Press, Taylor & Francis: New York, NY, 2008.
9. Chow SC, Hsieh E, Chi E, Yang J. A comparison of moment-based and probability-based criteria for assessment of follow-on biologics. Journal of Biopharmaceutical Statistics 2010; 20:31-45.
10. Hsieh TC, Chow SC, Liu JP, Hsiao CF, Chi E. Statistical test for evaluation of biosimilarity in variability of follow-on biologics. Journal of Biopharmaceutical Statistics 2010; 20:75-89.
11. Chow SC. Individual bioequivalence - a review of FDA draft guidance. Drug Information Journal 1999; 33:435-444.